Shares of Zelira Therapeutics Limited (OTCMKTS:ZLDAF – Get Free Report) traded down 6% during mid-day trading on Thursday . The stock traded as low as $0.33 and last traded at $0.33. 200 shares were traded during trading, a decline of 20% from the average session volume of 250 shares. The stock had previously closed at $0.35.
Zelira Therapeutics Stock Performance
The business’s fifty day moving average price is $0.39 and its 200 day moving average price is $0.45.
About Zelira Therapeutics
Zelira Therapeutics Limited, a bio-pharmaceutical company, engages in the research, development, and commercialization of cannabinoid-based medicines for the treatment of various medical conditions in Australia and the United States. The company offers formulations under the HOPE brand in Australia, Washington, Pennsylvania, and Louisiana, as well as develops Zenivol, a cannabinoid-based medicine for treatment of chronic insomnia.
Recommended Stories
- Five stocks we like better than Zelira Therapeutics
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Bloom Energy: Powering the Future With Decentralized Energy
- Ride Out The Recession With These Dividend Kings
- Dividend Powerhouses: Blue-Chip Stocks Built for the Long Haul
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Why Traders Are Buying the Dip on Johnson & Johnson Stock
Receive News & Ratings for Zelira Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zelira Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
